Clinicopathological characteristics and prognosis of patients with multiple primary melanomas

This narrative review provides an evidence-based overview of existing literature on the epidemiology, clinicopathological characteristics and prognostic outcomes of tumours arising in patients with multiple primary melanomas (MPM). PubMed and MEDLINE were searched for original research papers and review articles from 2000 to 2016 using the term ‘multiple primary melanoma.’ Population-wide increases in life expectancy, advances in early detection and increasing incidence of melanoma give rise to an expanding group of patients that are at an increased risk of developing subsequent primary tumours. This article is protected by copyright. All rights reserved.

[1]  H. Soyer,et al.  Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study. , 2016, The Journal of investigative dermatology.

[2]  E. M. Warton,et al.  Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. , 2015, Journal of the American Academy of Dermatology.

[3]  L. Arends,et al.  Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta‐analysis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  S. Rosso,et al.  Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[5]  H. Soyer,et al.  Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010. , 2014, JAMA dermatology.

[6]  D. Schadendorf,et al.  Incidence of new primary melanomas after diagnosis of stage III and IV melanoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Rosso,et al.  Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study. , 2013, JAMA dermatology.

[8]  M. Atkins,et al.  Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma , 2012, Cancer.

[9]  S. Rosso,et al.  Clinicopathologic Features of Incident and Subsequent Tumors in Patients with Multiple Primary Cutaneous Melanomas , 2012, Annals of Surgical Oncology.

[10]  J. Stein,et al.  Single versus multiple primary melanomas , 2012, Cancer.

[11]  P. Savoia,et al.  Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34‐year single‐institution study , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  L. Akslen,et al.  MC1R, ASIP, TYR, and TYRP1 gene variants in a population‐based series of multiple primary melanomas , 2012, Genes, chromosomes & cancer.

[13]  K. Brown,et al.  A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma , 2011, Nature.

[14]  Pragna Patel,et al.  Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. , 2011, Journal of the American Academy of Dermatology.

[15]  N. Martin,et al.  Nevi, family history, and fair skin increase the risk of second primary melanoma. , 2011, The Journal of investigative dermatology.

[16]  V. de Giorgi,et al.  Multiple primary melanoma: the impact of atypical naevi and follow up , 2010, The British journal of dermatology.

[17]  A. Stromberg,et al.  Second Primary Melanomas: Incidence and Outcome , 2010, The American surgeon.

[18]  P. Queirolo,et al.  CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma , 2008, Pigment cell & melanoma research.

[19]  A. Halpern,et al.  Clinicopathological features of and risk factors for multiple primary melanomas. , 2005, JAMA.

[20]  M. Tucker,et al.  Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  J. Malvehy,et al.  Role of the CDKN2A locus in patients with multiple primary melanomas. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  S. Menzies,et al.  Enhanced survival in patients with multiple primary melanoma. , 2003, Archives of dermatology.

[23]  Hensin Tsao,et al.  A population‐based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors , 2003, Cancer.